1 of 12

Nickel in the exposed Implant Braze Joint

Biocompatibility, Risks and Next Steps

Summer 2023 Intern Research Project

Reya Mehta

2 of 12

Introduction

  • The implant braze joint has nickel and titanium alloyed together (refer to part number 10132-01 rev A for the preform, 10136-01 rev A for the nickel-titanium material)
  • Nickel is known to be allergenic and not very biocompatible (Brown et al., 2020; Tsang et al., 2018).
  • Questions: What causes nickel-related adverse reactions? Is there pure nickel on the surface of the braze joint? How do we test that the implant is safe inside the human body?

​

3 of 12

4 of 12

5 of 12

Biocompatibility of Nickel

  • Corrosion of nickel → allergic contact dermatitis.
  • Most common allergic responses to neuromodulatory implants with nickel are local dermatitis, erythema, and pruritus (Brown et al., 2020).
  • Prevalence of nickel allergy is rising as metals are more frequently used in everyday life
    • Ear piercings
    • Women are more likely to have a nickel allergy
  • Possible long-term risk as the allergy can, in rare cases, be induced by nickel exposure

6 of 12

Nickel in Ni-Ti Brazing

  • After the brazing process, is there still free, unbonded nickel on the surface of the implant?
  • Ramp rates when brazing must be high to ensure that the nickel doesn’t melt before titanium – to prevent liquation (Panteli et al., 2012)
  • Jiang et al., 2005 had a similar preform to SPM – found no exposed free nickel
    • Carried out biocompatibility testing in sheep, results were positive

7 of 12

8 of 12

Does the SPM Implant Braze Joint have exposed Nickel?

9 of 12

Technical Considerations for Non-Clinical Assessment of Medical Devices Containing Nitinol

10 of 12

FDA Guidance

​

​

​

​

​

11 of 12

ASTM standard

  • Pending Kevin purchase (and Sheri quote)

12 of 12

Next Steps

  • Does SetPoint want to perform nickel ion leach testing?
  • If yes, officially for DVT/FDA submission? Unofficially for internal ER?
  • Pros: more data; ability to re-evaluate early if results are not ideal; ability to present to FDA if results are ideal
  • Cons: potentially expensive, time-consuming, and may require additional testing if results are unexpected
  • If yes, we should request quotes (for official short-term and long-term trials) from Element or Exponent